An appraisal of the published literature on the safety and toxicity of food-related nanomaterials

Critical Reviews in Toxicology

Volumn 41, Issue 1, 2011, Pages 20-49

  Card, Jeffrey W ^a,b   Jonaitis, Tomas S ^a   Tafazoli, Shahrzad ^a   Magnuson, Bernadene A ^a  

^a Cantox Health Sciences International   (Canada)

^b Ashuren Health Sciences   (Canada)

Author keywords

Nanomaterial; nanoparticle; nanotechnology; nutrition; study quality

Indexed keywords

ALUMINUM DERIVATIVE; CALCIUM CARBONATE; CHITOSAN; CHOLESTIN; CITRATE CALCIUM; COLECALCIFEROL; COPPER; FULLERENE DERIVATIVE; IRON; METHACRYLIC ACID METHYL ESTER; NANOMATERIAL; POLY(N ISOPROPYLACRYLAMIDE); POLYSTYRENE; SELENIUM; SILVER NANOPARTICLE; SINGLE WALLED NANOTUBE; SITOSTEROL DERIVATIVE; TITANIUM DIOXIDE; ZINC;

ANOREXIA; CHEMICAL PARAMETERS; CYTOTOXICITY; DIARRHEA; FOOD INTAKE; GENOTOXICITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LETHARGY; MEDICAL LITERATURE; NANOTECHNOLOGY; NONHUMAN; PHYSICAL CHEMISTRY; REVIEW; SOYBEAN; TOXICOLOGY; VOMITING;

MUS; RATTUS;

EID: 78651380972     PISSN: 10408444     EISSN: 15476898     Source Type: Journal    
DOI: 10.3109/10408444.2010.524636     Document Type: Review

References (112)

1. Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE. (2009). Nanoparticle interaction with plasma proteins as it relates to particle bio-distribution, biocompatibility and therapeutic efcacy. Adv Drug Deliv Rev 61:428-437.
2. Alkilany AM, Nagaria PK, Hexel CR, Shaw TJ, Murphy CJ, Wyatt MD. (2009). Cellular uptake and cytotoxicity of gold nanorods: Molecular origin of cytotoxicity and surface efects. Small 5:701-708.
3. Aprahamian M, Michel C, Humbert W, Devissaguet JP, Damge C. (1987). Transmucosal passage of polyalkylcyanoacrylate nanocapsules as a new drug carrier in the small intestine. Biol Cell 61:69-76.
4. Araujo L, Lobenberg R, Kreuter J. (1999). Infuence of the surfactant concentration on the body distribution of nanoparticles. J Drug Target 6:373-385.
5. Astete CE, Sabliov CM. (2006). Synthesis and characterization of PLGA nano-particles. J Biomater Sci Polym Ed 17:2472-89.
6. Aschberger K, Johnston HJ, Stone V, Aitken RJ, Lang Tran C, Hankin SM, Peters SA, Christensen FM et al. (2010). Review of fullerene toxicity and exposure - -Appraisal of a human health risk assessment, based on open literature. Regul Toxicol Pharmacol. 2010 Aug 25. Epub, ahead of print.
7. Aschberger K, Johnston HJ, Stone V, Aitken RJ, Hankin SM, Peters SA, Lang Tran C Christensen FM et al. (In press). Review of carbon nanotubes toxicity and exposure - -Appraisal of a human health risk assessment, based on open literature. Crit Rev Toxicol 40:759-790.
8. Back EI, Frindt C, Ocenásková E, Nohr D, Stern M, Biesalski HK. (2006). Can changes in hydrophobicity increase the bioavailability of α-tocopherol? Eur J Nutr 45:1-6.
9. Balasubramanyam A, Sailaja N, Mahboob M, Rahman MF, Misra S, Hussain SM, et al. (2009). Evaluation of genotoxic efects of oral exposure to aluminum oxide nanomaterials in rat bone marrow. Mutat Res 676:41-47.
10. Barrett EG, Johnston C, Oberdorster G, Finkelstein JN. (1999). Silica binds serum proteins resulting in a shift of the dose-response for silica-induced chem-okine expression in an alveolar type II cell line. Toxicol Appl Pharmacol 161:111-122.
11. Behrens I, Pena AI, Alonso MJ, Kissel T. (2002). Comparative uptake studies of bioadhesive and non-bioadhesive nanoparticles in human intestinal cell lines and rats: The efect of mucous on particle adsorption and transport. Pharm Res 19:1185-1193.
12. Bhol KC, Schechter PJ. (2007). Efects of nanocrystalline silver (NPI 32101) in a rat model of ulcerative colitis. Dig Dis Sci 52:2732-2742.
13. Bisht S, Feldmann G, Koorstra JB, Mullendore M, Alvarez H, Karikari C et al. (2008). In vivo characterization of a polymeric nanoparticle platform with potential oral drug delivery capabilities. Mol Cancer Ter 7:3878-3888.
14. Borm PJA, Robbins D, Haubold S, Kuhlbusch T, Fissan H, Donaldson K et al. (2006). The potential risks of nanomaterials: A review carried out for ECETOC. Part Fibre Toxicol 3:11 [1-35].
15. Bouwmeester H, Dekkers S, Noordam MY, Hagens WI, Bulder AS, de Heer C et al. (2009). Review of health safety aspects of nanotechnologies in food production. Regul Toxicol Pharmacol 53:52-62.
16. Card JW, Magnuson BA. (2010). A method to asses the quality of studies that examine the toxicity of engineered nanomaterials. Int J Toxicol 29:402-410.
17. Casey A, Herzog E, Lyng FM, Byrne HJ, Chambers G, Davoren M. (2008). Single walled carbon nanotubes induce indirect cytotoxicity by medium depletion in A549 lung cells. Toxicol Lett 179:78-84.
18. Chan Y-C, Wu C-C, Chan K-C, Lin Y-G, Liao J-W, Wang M-F et al. (2009). Nanonized black soybean enhances immune response in senescence-accelerated mice. Int J Nanomed 4:27-35.
19. Characterization Matters. (2008). Recommended Minimum Physical and Chemical Parameters for Characterizing Nanomaterials on Toxicology Studies. Developed at: Workshop on Ensuring Appropriate Material Characterization in Nano-toxicity Studies, Oct. ober 28-29, 2008, Washington, DC. Characterization Matters, The Minimum Information for Nanomaterial Characterization (MINChar) Initiative. Nov. ember 24, 2008. Available at: http://characterizationmatters. fles.wordpress. com/2008/11/minchar-parameters-list.pdf. Accessed 14 April 2010.
20. Chaudhry Q, Scotter M, Blackburn J, Ross B, Boxall A, Castle L et al. (2008). Applications and implications of nanotechnologies for the food sector. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 25:241-258.
21. Chen HH, Yu C, Ueng TH, Chen S, Chen BJ, Huang KJ et al. (1998). Acute and subacute toxicity study of water-soluble polyalkylsulfonated c60 in rats. Toxicol Pathol 26:143-151.
22. Chen H, Weiss J, Shahidi F. (2006a). Nanotechnology in nutraceuticals and functional foods. Food Technol 60:30-36.
23. Chen Z, Meng H, Xing G, Chen C, Zhao Y, Jia G et al. (2006b). Acute toxicological efects of copper nanoparticles in vivo. Toxicol Lett 163:109-120.
24. Chen HS, Chang JH, Wu JSB. (2008). Calcium bioavailability of nanonized pearl powder for adults. J Food Sci 73:H246-H251.
25. Coyle P, Philcox JC, Carey LC, Rofe AM. (2002). Metallothionein: The multipurpose protein. Cell Mol Life Sci 59:627-647.
26. De Jong WH, Hagens WI, Krystek P, Burger MC, Sips AJ, Geertsma RE. (2008). Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 29:1912-1919.
27. des Rieux A, Fievez V, Garinot M, Schneider YJ, Préat V. (2006). Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach. J Control Release 116:1-27.
28. Desai MP, Labhasetwar V, Amidon GL, Levy RJ. (1996). Gastrointestinal uptake of biodegradable microparticles: Efect of particle size. Pharm Res 13:1838-1845.
29. Desai MP, Labhasetwar V, Walter E, Levy RJ, Amidon GL. (1997). The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm Res 14:1568-1573.
30. Doak SH, Grifths SM, Manshian B, Singh N, Williams PM, Brown AP et al. (2009). Confounding experimental considerations in nanogenotoxicology. Mutagenesis 24:285-293.
31. Dobrovolskaia MA, McNeil SE (2007). Immunological properties of engineered nanomaterials. Nat Nanotechnol 2:469-478.
32. Dutta D, Sundaram SK, Teeguarden JG, Riley BJ, Fifeld LS, Jacobs JM, et al. (2007). Adsorbed proteins infuence the biological activity and molecular targeting of nanomaterials. Toxicol Sci 100:303-315.
33. El-Sayed M, Rhodes CA, Ginski M, Ghandehari H. (2003). Transport mechanism(s) of poly (amidoamine) dendrimers across caco-2 cell mon-olayers. Int J Pharm 265:151-157.
34. Florence AT. (1997). The oral absorption of micro-and nanoparticulates: Neither exceptional nor unusual. Pharm Res 14:259-266.
35. Florence AT. (2005). Nanoparticle uptake by the oral route: Fulflling its potential? Drug Discov Today Technol 2:75-81.
36. Folkmann JK, Risom L, Jacobsen NR, Wallin H, Loft S, Moller P. (2009). Oxidatively damaged DNA in rats exposed by oral gavage to C(60) fuller-enes and single-walled carbon nanotubes. Environ Health Perspect 117:703-708.
37. Gajdoíková A, Gajdoík A, Koneracká M, Záviová V, Štvrtina S, Krchnárová V et al. (2006). Acute toxicity of magnetic nanoparticles in mice. Neuroendocrinol Lett 27(Suppl. 2):96-99.
38. Ghosh A, Mandal AK, Sarkar S, Panda S, Das N. (2009). Nanoencapsulation of quercetin enhances its dietary efcacy in combating arsenic-induced oxidative damage in liver and brain of rats. Life Sci 84:75-80.
39. Gonzalez L, Lison D, Kirsch-Volders M. (2008). Genotoxicity of engineered nanomaterials: A critical review. Nanotoxicology 2:252-273.
40. Goodman CM, McCusker CD, Yilmaz T, Rotello VM. (2004). Toxicity of gold nan-oparticles functionalized with cationic and anionic side chains. Bioconjug Chem 15:897-900.
41. Guo L, Von Dem Bussche A, Buechner M, Yan A, Kane AB, Hurt RH. (2008). Adsorption of essential micronutrients by carbon nanotubes and the implications for nanotoxicity testing. Small 4:721-727.
42. Hagens WI, Oomen AG, de Jong WH, Cassee FR, Sips AJ. (2007). What do we (need to) know about the kinetic properties of nanoparticles in the body? Regul Toxicol Pharmacol 49:217-229.
43. Hall JB, Dobrovolskaia MA, Patri AK, McNeil SE. (2007). Characterization of nanoparticles for therapeutics. Nanomedicine (London) 2:789-803.
44. Hardman R. (2006). A toxicologic review of quantum dots: Toxicity depends on physico-chemical and environmental factors. Environ Health Perspect 114:165-172.
45. Hillery AM, Jani PU, Florence AT. (1994). Comparative, quantitative study of lymphoid and non-lymphoid uptake of 60 nm polystyrene particles. J Drug Target 2:151-156.
46. Hillyer JF, Albrecht RM. (2001). Gastrointestinal persorption and tissue distribution of diferently sized colloidal gold nanoparticles. J Pharm Sci 90:1927-1936.
47. Hoet P, Bruske-Hohlfeld I, Salata O. (2004). Nanoparticles - -Known and unknown health risks. Journal of Nanobiotechnology 2:12.
48. Huang S, Chen JC, Hsu CW, Chang WH. (2009). Efects of nano calcium carbonate and nano calcium citrate on toxicity in ICR mice and on bone mineral density in an ovariectomized mice model. Nanotechnology 20:Paper 375102.
49. Hussain N, Jani PU, Florence AT. (1997). Enhanced oral uptake of tomato lectin-conjugated nanoparticles in the rat. Pharm Res 14:613-618.
50. Hussain N, Florence AT. (1998). Utilizing bacterial mechanisms of epithelial cell entry: Invasin-induced oral uptake of latex nanoparticles. Pharm Res 15:153-156.
51. Hussain N, Jani PU, Florence AT. (1997). Enhanced oral uptake of tomato lectin-conjugated nanoparticles in the rat. Pharm Res 14:613-618.
52. Ishida T, Harashima H, Kiwada H. (2002). Liposome clearance. Biosci Rep 22:197-1224.
53. Jani P, Halbert GW, Langridge J, Florence AT. (1989). The uptake and transloca-tion of latex nanospheres and microspheres after oral administration to rats. J Pharm Pharmacol 41:809-812.
54. Jani P, Halbert GW, Langridge J, Florence AT. (1990). Nanoparticle uptake by the rat gastrointestinal mucosa: Quantitation and particle size dependency. J Pharm Pharmacol 42:821-826.
55. Jevprasesphant R, Penny J, Attwood D, McKeown NB, D'Emanuele A. (2003). Engineering of dendrimer surfaces to enhance transepithelial transport and reduce cytotoxicity. Pharm Res 20:1543-1550.
56. Jia X, Li N, Chen J. (2005). A subchronic toxicity study of elemental Nano-Se in Sprague-Dawley rats. Life Sci 76:1989-2003.
57. Jones CF, Grainger DW. (2009). In vitro assessments of nanomaterial toxicity. Adv Drug Deliv Rev 61:438-456.
58. Keller S, Helbig D, Härtl A, Jahreis G. (2007). Nanoscale and customary non-esterifed sitosterols are equally enriched in diferent body compartments of the guinea pig. Mol Nutr Food Res 51:1503-1509.
59. Kim YS, Kim JS, Cho HS, Rha DS, Kim JM, Park JD et al. (2008). Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. Inhal Toxicol 20:575-583.
60. Kitchens KM, Foraker AB, Kolhatkar RB, Swaan PW, Ghandehari H. (2007). Endocytosis and interaction of poly (amidoamine) dendrimers with Caco-2 cells. Pharm Res 24:2138-2145.
61. Klimisch H-J, Andreae M, Tillmann U. (1997). A systematic approach for evaluating the quality of experimental toxicological and ecotoxicological data. Regul Toxicol Pharmacol 25:1-5.
62. Koeneman BA, Zhang Y, Hristovski K, Westerhof P, Chen Y, Crittenden JC et al. (2009). Experimental approach for an in vitro toxicity assay with non- aggregated quantum dots. Toxicol In Vitro 23:955-962.
63. Li HL, Zhao XB, Ma YK, Zhai GX, Li L, Lou HX. (2009). Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. J Control Release 133:238-244.
64. Li SD, Huang L. (2008). Pharmacokinetics and biodistribution of nanoparticles. Mol Pharm 5:496-504.
65. Longmire M, Choyke PL, Kobayashi H. (2008). Dendrimer-based contrast agents for molecular imaging. Curr Top Med Chem 8:1180-1186.
66. Lovric J, Bazzi HS, Cuie Y, Fortin GR, Winnik FM, Maysinger D. (2005). Diferences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots. J Mol Med 83:377-385.
67. McCullough JS, Hodges GM, Dickson GR, Yarwood A, Carr KE. (1995). A morphological and microanalytical investigation into the uptake of particulate iron across the gastrointestinal tract of rats. J Submicrosc Cytol Pathol 27:119-124.
68. Meng H, Chen Z, Xing G, Yuan H, Chen C, Zhao F et al. (2007). Ultrahigh reactivity provokes nanotoxicity: Explanation of oral toxicity of nano-copper particles. Toxicol Lett 175:102-110.
69. Mori T, Takada H, Ito S, Matsubayashi K, Miwa N, Sawaguchi T. (2006). Preclinical studies on safety of fullerene upon acute oral administration and evaluation for no mutagenesis. Toxicology 225:48-54.
70. NCI/NCL. (2009). Assay Cascade Protocols. Frederick, (MD): National Cancer Institute (NCI), Nanotechnology Characterization Laboratory (NCL). Available at: http://ncl.cancer.gov/working-assay-cascade.asp. Accessed 14 April 2010.
71. Oberdörster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K et al. (2005). Principles for characterizing the potential human health efects from exposure to nanomaterials: Elements of a screening strategy (ILSI Research Foundation/Risk Science Institute Nanomaterial Toxicity Screening Working Group). Part Fibre Toxicol 2:8 [1-35].
72. Ogawara K, Yoshida M, Higaki K, Kimura T, Shiraishi K, Nishikawa M et al. (1999). Hepatic uptake of polystyrene microspheres in rats: Efect of particle size on intrahepatic distribution. J Control Release 59:15-22.
73. Owen RL. (1977). Sequential uptake of horseradish peroxidase by lymphoid follicle epithelium of Peyer's patches in the normal unobstructed mouse intestine: An ultrastructural study. Gastroenterology 72:440-41.
74. Pisal DS, Yellepeddi VK, Kumar A, Palakurthi S. (2008). Transport of surface engineered polyamidoamine (PAMAM) dendrimers across IPEC-J2 cell monolayers. Drug Deliv 15:515-522.
75. Poole CP Jr, Owens FJ. (2003). Introduction to Nanotechnology. Hoboken, (NJ): John Wiley & Sons, Inc.
76. Powers KW, Brown SC, Krishna VB, Wasdo SC, Moudgil BM, Roberts SM. (2006). Research strategies for safety evaluation of nanomaterials. Part VI. characterization of nanoscale particles for toxicological evaluation. Toxicol Sci 90:296-303.
77. Rajagopalan P, Wudl F, Schinazi RF, Boudinot FD. (1996). Pharmacokinetics of a water-soluble fullerene in rats. Antimicrob Agents Chemother 40:2262-2265.
78. Rhoades J, Roller S. (2000). Antimicrobial actions of degraded and native chi-tosan against spoilage organisms in laboratory media and foods. Appl Environ Microbiol 66:80-86.
79. Rogers NJ, Franklin NM, Apte SC, Batley GE. (2007). The importance of physical and chemical characterization in nanoparticle toxicity studies. Integr Environ Assess Manag 3:303-304.
80. Rohner F, Ernst FO, Arnold M, Hilbe M, Biebinger R, Ehrensperger F et al. (2007). Synthesis, characterization, and bioavailability in rats of ferric phosphate nanoparticles. J Nutr 137:614-619.
81. Rothen-Rutishauser BM, Schurch S, Haenni B, Kapp N, Gehr P. (2006). Interaction of fne particles and nanoparticles with red blood cells visualized with advanced microscopic techniques. Environ. Sci. Technol 40:4353-4359.
82. Russell-Jones GJ, Arthur L, Walker H. (1999). Vitamin B12-mediated transport of nanoparticles across Caco-2 cells. Int J Pharm 179:247-255. (Pubitemid 29131434)
83. Salamat-Miller N, Johnston TP. (2005). Current strategies used to enhance the paracellular transport of therapeutic polypeptides across the intestinal epithelium. Int J Pharm 294:201-216.
84. Schneider K, Schwarz M, Burkholder I, Kopp-Schneider A, Edler L, Kinsner-Ovaskainen A et al. (2009). "ToxRTool", a new tool to assess the reliability of toxicological data. Toxicol Lett 189:138-144.
85. Shea TB, Ortiz D, Nicolosi RJ, Kumar R, Watterson AC. (2005). Nanosphere-mediated delivery of vitamin E increases its efcacy against oxida-tive stress resulting from exposure to amyloid beta. J Alzheimers Dis 7:297-301.
86. Sinaga E, Jois SD, Avery M, Makagiansar IT, Tambunan US, Audus KL et al. (2002). Increasing paracellular porosity by E-cadherin peptides: Discovery of bulge and groove regions in the EC1-domain of E-cadherin. Pharm Res 19:1170-1179.
87. Singh R, Pantarotto D, Lacerda L, Pastorin G, Klumpp C, Prato M et al. (2006). Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proc Natl Acad Sci USA 103:3357-3362.
88. Sneller MC, Strober W. (1986). M cells and host defense. J Infect Dis 154:737-741.
89. Sonaje K, Italia JL, Sharma G, Bhardwaj V, Tikoo K, Ravi Kumar MNV. (2007). Development of biodegradable nanoparticles for oral delivery of ellagic acid and evaluation of their antioxidant efcacy against cyclosporine A-induced nephrotoxicity in rats. Pharm Res 24:899-908.
90. Sonavane G, Tomoda K, Sano A, Ohshima H, Terada H, Makino K. (2008). In vitro permeation of gold nanoparticles through rat skin and rat intestine: Efect of particle size. Colloids Surf B Biointerfaces 65:1-10.
91. Stern ST, McNeil SE. (2008). Nanotechnology safety concerns revisited. Toxicol Sci 101:4-21.
92. Szentkuti L. (1997). Light microscopical observations on luminally administered dyes, dextrans, nanospheres and microspheres in the pre-epithelial mucous gel layer of the rat distal colon. J Control Release 46:233-242.
93. Tuinier R, de Kruif GC. (2002). Stability of casein micelles in milk. J Chem Phys 117(3):1290-1295.
94. Volkheimer G, Schulz FH, Aurich I, Strauch S, Beuthin K, Wendlandt, H. (1968). Persorption of particles. Digestion 1(2):78-80.
95. Wang B, Feng W-Y, Wang T-C, Jia G, Wang M, Shi J-W et al. (2006). Acute toxic-ity of nano- and micro-scale zinc powder in healthy adult mice. Toxicol Lett 161:115-123.
96. Wang J, Zhou G, Chen C, Yu H, Wang T, Ma Y et al. (2007). Acute toxicity and biodistribution of diferent sized titanium dioxide particles in mice after oral administration. Toxicol Lett 168:176-185.
97. Wang L, Nagesha DK, Selvarasah S, Dokmeci MR, Carrier RL. (2008). Toxicity of CdSe nanoparticles in Caco-2 cell cultures. J Nanobiotechnol 6:11.
98. 2 particles as a component of nanoparticle risk management. Toxicol Lett 171:99-110.
99. Warheit DB, Sayes CM, Reed KL, Swain KA. (2008). Health efects related to nanoparticle exposures: Environmental, health and safety considerations for assessing hazards and risks. Pharmacol Ter 120:35-42.
100. Weiss J, Takhistov P, Mcclements DJ. (2006). Functional materials in food nan-otechnology. J Food Sci 71:R107-R116.
101. Weiss J, Gaysinsky S, Davidson M, McClements J (2009). Nanostructured encapsulation systems: Food antimicrobials (Chapter 24). In: Barbosa-Canovas G, editor. Global Issues in Food Science and Technology. London, Engl.: Academic Press, pp. 425-480.
102. Wolf JL, Bye WA. (1984). The membranous epithelial (M) cell and the mucosal immune system. Annu Rev Med 35:95-112.
103. Xu ZR, Han XY, Wang YZ (2004). Efects on growth and cadmium residues from feeding cadmium-added diets with and without montmorillonite nano-composite to growing pigs. Vet Hum Toxicol 46:238-241.
104. 14C labeling, absorption, distribution, excretion and acute toxicity. Chem Biol 2:385-389.
105. Yang W, Shen C, Ji Q, An H, Wang J, Liu Q et al. (2009). Food storage material silver nanoparticles interfere with DNA replication fdelity and bind with DNA. Nanotechnology 20:085102.
106. Yoksan R, Chirachanchai S. (2008). Amphiphilic chitosan nanosphere: Studies on formation, toxicity, and guest molecule incorporation. Bioorg Med Chem 16:2687-2696.
107. Yoo S, Park GT. (2004). Biodegradable nanoparticles containing protein-fatty acid complexes for oral delivery of salmon calcitonin. J Pharm Sci 93:488-495.
108. Yu C-C, Wang J-J, Lee C-L, Lee S-H, Pan T-M. (2008). Safety and mutagenic-ity evaluation of nanoparticulate red mold rice. J Agric Food Chem 56:11038-11048.
109. Yuan H, Chen J, Du Y-Z, Hu F-Q, Zeng S, Zhao H-L. (2007). Studies on oral absorption of stearic acid SLN by a novel fuorometric method. Colloids Surf B Biointerfaces 58:157-164.
110. Zha L-Y, Xu Z-R, Wang M-Q, Gu L-Y. (2008). Chromium nanoparticle exhibits higher absorption efciency than chromium picolinate and chromium chloride in Caco-2 cell monolayers. J Anim Physiol Anim Nutr 92:131-140.
111. Zhang J, Gao X, Zhang L, Bao Y. (2001). Biological efects of a nano red elemental selenium. Biofactors 15:27-38.
112. Zhang J, Wang H, Yan X, Zhang L. (2005). Comparison of short-term toxicity between Nano-Se and selenite in mice. Life Sci 76:1099-1109.